• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Monday 09/24/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Two Group JSC

  • 12:40 PM

    NEWPORT BEACH, Calif., Oct. 10, 2017, VMNT, (GLOBE NEWSWIRE) — Vemanti Group, Inc. (OTC PINK:VMNT), a diversified holding corporation, today announces that it has entered into a Letter of Intent (LOI) to acquire 100% of assets from Two Group, JSC (“TGJ”), an internet technology conglomerate based in HCMC, Vietnam, to move towards closing the Company’s first strategic investments into Vietnam. Vietnam continues to be one of Asia’s most compelling investment stories. With 93 million people – average age of 28

    Read more
  • 4:23 PM

    VALENCIA, SPAIN–(Marketwired – Dec 17, 2014) – Zenosense, Inc. (OTCQB: ZENO) (“Zenosense”, the “Company”), a healthcare technology company primarily focused on developing and marketing devices to detect the MRSA “Super-Bug” and to detect signs of lung cancer in exhaled breath, is pleased to announce that on 16 December 2014, the Company’s development partner, Zenon Biosystem (Zenon) entered into a collaboration agreement for a lung cancer detection trial. The agreement is with a university and a large university hospital located in the region

    Read more
  • 3:02 PM

    VALENCIA, SPAIN, Dec 04, 2014 (Marketwired via COMTEX) — Zenosense, Inc. (OTCQB: ZENO) (“Zenosense”, the “Company”), a healthcare technology company primarily focused on developing and marketing devices to detect the MRSA “Super-Bug” and to detect signs of lung cancer in exhaled breath, is pleased to announce that Depository Trust Corporation (DTC) has approved Zenosense common stock for DWAC/FAST transfer through Zenosense’s transfer agent, Action Stock Transfer Corporation. With this approved stock transfer capability Zenosense shareholders can transfer their shares of

    Read more
  • 8:09 PM

    Oct 27, 2014 (eTeligis.com via COMTEX) — VALENCIA, Spain, via ETELIGIS INC., 10/27/2014 – – Zenosense, Inc. (OTCQB: ZENO) (“Zenosense”, the “Company”), a healthcare technology company primarily focused on developing and marketing devices to detect the MRSA “Super-Bug” and to detect signs of lung cancer in exhaled breath, is pleased to announce considerable progress made in the development of its MRSA/SA detector. The prototype device successfully achieved a sensibility detection rate greater than 95% on cultured headspace in a series

    Read more
  • 3:55 PM

    VALENCIA, SPAIN, Nov 04, 2014 (Marketwired via COMTEX) — Zenosense, Inc. (OTCQB: ZENO) (“Zenosense,” the “Company”), a healthcare technology company primarily focused on developing and marketing devices to detect the MRSA “Super-Bug” and to detect signs of lung cancer in exhaled breath, is pleased to announce the manufacturing of a pre-commercial prototype device to be evaluated for the detection of lung cancer in exhaled breath (“Device”). Prototyping manufacture is well advanced. The work has been undertaken by the Company’s contracted

    Read more
Public Wire Banner